Detalhe da pesquisa
1.
Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
BMC Cancer
; 23(1): 1217, 2023 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066499
2.
Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
BMC Cancer
; 23(1): 1146, 2023 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007428
3.
Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA.
BMC Cancer
; 22(1): 858, 2022 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932022
4.
Combination of smoking and Epstein-Barr virus DNA is a predictor of poor prognosis for nasopharyngeal carcinoma: a long-term follow-up retrospective study.
BMC Cancer
; 22(1): 1262, 2022 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36471255
5.
Effects of writers, erasers and readers within miRNA-related m6A modification in cancers.
Cell Prolif
; 56(1): e13340, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162823
6.
Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma.
J Cancer Res Clin Oncol
; 149(1): 191-202, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36595043